cdk4/6 inhibitors & endocrine therapy in breast cancer
Published 5 years ago • 88 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
6:05
cdk4/6 inhibitors & endocrine therapy: selecting a regimen
-
6:46
cdk4/6 inhibitors & endocrine therapy: treatment resistance
-
4:35
cdk4/6 inhibitors & endocrine therapy: adverse events
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
4:15
case 2: choosing a cdk4/6 inhibitor in er breast cancer
-
4:37
case 2: cdk4/6 inhibitors in er breast cancer
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
1:58
dr. yardley on endocrine therapy plus cdk4/6 inhibitors in breast cancer with visceral metastases
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
3:32
cdk4/6 plus endocrine therapy as first-line approach
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
6:13
case 2: cdk4/6 inhibitor recommendations in er breast cancer
-
3:21
benefits and challenges of cdk4/6 inhibitors